Source:http://linkedlifedata.com/resource/pubmed/id/10813541
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-8-21
|
pubmed:abstractText |
High-dose chemotherapy followed by autologous PBSC transplantation (PBSCT) has become an accepted form of therapy for a number of malignant hematologic diseases. The optimal method for the collection of PBSC is yet to be defined. Large-volume leukapheresis may be able to collect adequate numbers of PBSC with the patient undergoing fewer procedures. We routinely process 7 L of blood per leukapheresis. Hence, we elected to assess whether a modest increase in the blood volume processed would, on average, decrease the number of leukaphereses each patient needed to undergo to collect > or =2 x 10(6) CD34+ cells/kg body weight. Sixty patients were randomized to undergo 7 L leukaphereses (n = 31 patients; 87 leukaphereses) or 10 L leukaphereses (n = 29 patients; 81 leukaphereses). The median number of leukaphereses required per patient to collect the target number of CD34+ cells was two (range one to five) for both groups (p = 0.83). The median number of nucleated cells collected per patient was greater for the 10 L group (8.2 x 10(8)/kg versus 5.3 x 10(8)/kg, p = 0.005), as was the median number of mononuclear cells (MNC) (4.7 x 10(8)/kg versus 3.6 x 10(8)/kg, p = 0.0001), whereas there was no statistical difference between the groups for the median number of CD34+ cells collected per patient (3.2 x 10(6)/kg versus 3.7 x 10(6)/kg, p = 0.98). Therefore, over the 18-month period of this trial, the use of a 10 L leukapheresis volume did not decrease the number of leukaphereses performed compared with a 7 L leukapheresis volume.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1525-8165
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
269-74
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10813541-Adolescent,
pubmed-meshheading:10813541-Adult,
pubmed-meshheading:10813541-Antigens, CD34,
pubmed-meshheading:10813541-Blood Cell Count,
pubmed-meshheading:10813541-Blood Volume,
pubmed-meshheading:10813541-Drug Tolerance,
pubmed-meshheading:10813541-Evaluation Studies as Topic,
pubmed-meshheading:10813541-Female,
pubmed-meshheading:10813541-Hemoglobins,
pubmed-meshheading:10813541-Humans,
pubmed-meshheading:10813541-Leukapheresis,
pubmed-meshheading:10813541-Male,
pubmed-meshheading:10813541-Middle Aged,
pubmed-meshheading:10813541-Patient Acceptance of Health Care,
pubmed-meshheading:10813541-Quality Control,
pubmed-meshheading:10813541-Questionnaires,
pubmed-meshheading:10813541-Time Factors
|
pubmed:year |
2000
|
pubmed:articleTitle |
A randomized trial of leukapheresis volumes, 7 L versus 10 L: an assessment of efficacy and patient tolerance.
|
pubmed:affiliation |
Bone Marrow Transplant Programme, Alfred Hospital, Melbourne, Australia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|